Recall one batche of Zicarb-200 (Dacarbazine)
2025-02-25
الاسم التجاري الاسم العلمي رقم التسجيل رقم التشغيلة المتأثرة الشركة الصانعة Trade Name Scientific Name Register Number Affected batch number Manufacturer Zicarb-200 (Dacarbazine) Dacarbazine Not registered 1426018 NEON LABORATORIES LIMITED
التصنيف
ملف
التاريخ
2025-02-23
اسم المستحضر
Zicarb-200 (Dacarbazine)
اجراء الاستدعاء
مستوى الاستدعاء
نوع المستحضر
سبب السحب
SFDA has issued a recall of one batche of Zicarb-200 tablet due to the product incompliance with the requirements of the executive regulations for the Pharmaceutical establishments system.
التوصيات
For healthcare professionals: Stop dispensing the affected batche immediately. Embargo/Quarantine all remaining stock. Affected batches should be returned to the supplier.
For patients,
- Consult your healthcare provider prior to discontinuing use of the affected batche, or for any health concerns.
- Contact the recalling firm or SFDA if you have any questions about the recall.
- Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.